Status:
COMPLETED
A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This 2 arm study will compare the efficacy and safety of the standard chemotherapy of the East German Study Group for Hematology and Oncology versus standard chemotherapy plus MabThera (375mg/m2 iv, o...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- advanced, low-grade non-Hodgkin's and mantle cell lymphoma.
Exclusion
- possibility of curative radiation therapy;
- secondary NHL;
- participation in another clinical trial eg with cytostatic chemotherapy or cytokines;
- concomitant diseases and/or restricted organ function precluding therapy according to the study protocol.
Key Trial Info
Start Date :
September 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00269113
Start Date
September 1 1998
End Date
April 1 2009
Last Update
July 23 2015
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin, Germany, 12203
2
Berlin, Germany, 13122
3
Bochum, Germany, 44791
4
Bonn, Germany, 53127